Patent ReferencesModified living canine parvovirus vaccine Patent #: 4303645 InventorAssigneeApplicationNo. 06/823333 filed on 01/28/1986US Classes:424/201.1, Combination of viral and bacterial antigens (e.g., multivalent viral and bacterial vaccine, etc.)424/233.1, Adenoviridae, adeno-like virus, or Parvoviridae (e.g., adenovirus, canine parvovirus, mink enteritis virus, hemorrhagic enteritis virus, feline panleukopenia virus, egg drop syndrome virus, etc.)424/818, VIRAL VACCINE FOR CANIDAE OR MUSTELIDAE (E.G., DOGS, FOXES, MINKS, ETC.)435/235.1, VIRUS OR BACTERIOPHAGE, EXCEPT FOR VIRAL VECTOR OR BACTERIOPHAGE VECTOR; COMPOSITION THEREOF; PREPARATION OR PURIFICATION THEREOF; PRODUCTION OF VIRAL SUBUNITS; MEDIA FOR PROPAGATING435/236Inactivation or attenuation; producing viral subunitsExaminersPrimary: Kepplinger, Esther M.Attorney, Agent or FirmInternational ClassesA61K 39/295 (20060101)C07K 14/005 (20060101) C07K 14/015 (20060101) A61K 39/00 (20060101) Foreign Application Priority Data1985-01-31 GBAbstractThe present invention concerns a vaccine comprising a novel canine parvovirus strain and having the property of being able to break through the maternally derived antibody levels persistent in 9-12 week old pups, and even to immunize the majority of pups at the age of 6 weeks in the presence of maternally derived antibodies.Other References
|
| ||||||||||||||